Y. Kemel

发表

Cancer Susceptibility Mutations in Patients With Urothelial Malignancies.

Kenneth Offit, Barry S Taylor, Vignesh Ravichandran, 2019, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Sources of Uncertainty About Daughters’ Breast Cancer Risk that Emerge During Genetic Counseling Consultations

Carla L. Fisher, C. Bylund, D. Brashers, 2012, Journal of Genetic Counseling.

Billing and Record-Keeping for Familial Cancer Risk Counseling: A National Survey

B. Bernhardt, B. Peshkin, Y. Kemel, 1998, Journal of Genetic Counseling.

Fumarate hydratase FH c.1431_1433dupAAA (p.Lys477dup) variant is not associated with cancer including renal cell carcinoma

M. Berger, C. Iacobuzio-Donahue, K. Offit, 2019, Human mutation.

Towards Automation of Germline Variant Curation in Clinical Cancer Genetics

Zarina Shameer, Kenneth Offit, Mark Robson, 2018, Genetics in Medicine.

Incorporating information regarding preimplantation genetic diagnosis into discussions concerning testing and risk management for BRCA1/2 mutations

K. Offit, L. Rubin, Y. Kemel, 2012, Cancer.

Understanding inherited risk in unselected newly diagnosed patients with endometrial cancer.

M. Berger, K. Offit, M. Robson, 2019, JCO precision oncology.

Collaborative Group of the Americas on Inherited Gastrointestinal Cancers (CGA-IGC) Annual Virtual Meeting, November 13–15, 2021

Kenneth, Amanda Catchings, E. Salo-Mullen, 2022, Familial Cancer.

Germline Variants Identified in Patients with Early-onset Renal Cell Carcinoma Referred for Germline Genetic Testing.

A. Lenis, M. Ladanyi, K. Offit, 2021, European urology oncology.

Diagnostic yield and clinical relevance of expanded genetic testing for cancer patients

M. Ladanyi, J. Reis-Filho, K. Offit, 2022, Genome Medicine.

Disparities in cancer genetics care by race/ethnicity among pan‐cancer patients with pathogenic germline variants

Carol L. Brown, M. Berger, K. Offit, 2022, Cancer.

Therapeutic Implications of Germline Testing in Patients With Advanced Cancers

N. Schultz, M. Ladanyi, M. Berger, 2021, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Frequency of actionable cancer predisposing germline mutations in patients with lung cancers.

David R. Jones, B. Taylor, M. Berger, 2018 .

Gene-based Confirmatory Germline Testing Following Tumor-only Sequencing of Prostate Cancer.

Y. Liu, A. Lenis, V. Laudone, 2022, European urology.

Cancer Causative Mutations Occurring in Early Embryogenesis.

L. Borsu, M. Ladanyi, M. Berger, 2021, Cancer discovery.

Molecular Classification of Appendiceal Adenocarcinoma

N. Schultz, M. Berger, D. Solit, 2022, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Pathogenic Loss-of-Function Germline TERT Mutations in Patients With Solid Tumors

K. Offit, M. Robson, Z. Stadler, 2019, JCO precision oncology.

Integrating somatic variant data and biomarkers for germline variant classification in cancer predisposition genes

K. Offit, S. Kulkarni, Kristy Lee, 2018, Human mutation.

The context-specific role of germline pathogenicity in tumorigenesis

B. Taylor, N. Schultz, M. Ladanyi, 2021, Nature Genetics.

Targeting Germline- and Tumor-Associated Nucleotide Excision Repair Defects in Cancer

B. Taylor, M. Berger, C. Rudin, 2020, Clinical Cancer Research.

Prevalence and Characterization of Biallelic and Monoallelic NTHL1 and MSH3 Variant Carriers From a Pan-Cancer Patient Population

C. Bourque, B. Taylor, M. Berger, 2021, JCO precision oncology.

Prospective Evaluation of Germline Alterations in Patients With Exocrine Pancreatic Neoplasms

M. Berger, C. Iacobuzio-Donahue, S. Leach, 2018, Journal of the National Cancer Institute.

Germline RAD51B variants confer susceptibility to breast and ovarian cancers deficient in homologous recombination

J. Reis-Filho, K. Offit, B. Weigelt, 2021, npj Breast Cancer.

Germline RAD51B variants confer susceptibility to breast and ovarian cancers deficient in homologous recombination

J. Reis-Filho, K. Offit, B. Weigelt, 2021, NPJ breast cancer.

11p15.5 epimutations in children with Wilms tumor and hepatoblastoma detected in peripheral blood

E. Papaemmanuil, K. Offit, A. Kentsis, 2020, Cancer.

Microsatellite Instability Is Associated With the Presence of Lynch Syndrome Pan-Cancer.

Ahmet Zehir, Kenneth Offit, Barry S Taylor, 2019, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Prospective pan-cancer germline testing using MSK-IMPACT informs clinical translation in 751 patients with pediatric solid tumors

N. Schultz, M. Ladanyi, M. Berger, 2021, Nature Cancer.

Ampullary cancer: Evaluation of somatic and germline genetic alterations and association with clinical outcomes

B. Taylor, M. Berger, C. Iacobuzio-Donahue, 2019, Cancer.

Human genetic disease caused by de novo mitochondrial-nuclear DNA transfer

D. Cooper, L. Biesecker, J. Johnston, 2003, Human Genetics.

Prevalence of Germline Mutations in Cancer Susceptibility Genes in Patients With Advanced Renal Cell Carcinoma

M. Ladanyi, K. Offit, R. Motzer, 2018, JAMA oncology.

Inherited Germline Cancer Susceptibility Gene Variants in Individuals with Non–Muscle-Invasive Bladder Cancer

M. Berger, K. Offit, I. Ostrovnaya, 2022, Clinical cancer research : an official journal of the American Association for Cancer Research.

Mutation Detection in Patients With Advanced Cancer by Universal Sequencing of Cancer-Related Genes in Tumor and Normal DNA vs Guideline-Based Germline Testing

P. Kantoff, M. Ladanyi, M. Berger, 2017, JAMA.

Four-year follow-up of outcomes following risk-reducing salpingo-oophorectomy in BRCA mutation carriers

C. Hudis, K. Offit, J. Boyd, 2005 .

Multiple Primary Cancers in Patients Undergoing Tumor-Normal Sequencing Define Novel Associations

V. Seshan, M. Ladanyi, M. Berger, 2021, Cancer Epidemiology, Biomarkers & Prevention.

Genomic Characterization of Renal Medullary Carcinoma and Treatment Outcomes

R. Motzer, J. Chaim, A. Hakimi, 2017, Clinical genitourinary cancer.

Germline SDHA mutations in children and adults with cancer

Ed Reznik, Alex Kentsis, Kenneth Offit, 2018, Cold Spring Harbor molecular case studies.

Pan-cancer microsatellite instability to predict for presence of Lynch syndrome.

B. Taylor, M. Berger, K. Offit, 2018, Journal of Clinical Oncology.

Fumarate hydratase c.914T > C (p.Phe305Ser) is a pathogenic variant associated with hereditary leiomyomatosis and renal cell cancer syndrome

O. Ceyhan-Birsoy, K. Breen, M. Carlo, 2020, Molecular genetics & genomic medicine.

MAPK pathway genetic alterations are associated with prolonged overall survival in low-grade serous ovarian carcinoma.

B. Weigelt, D. Chi, A. Iasonos, 2022, Clinical cancer research : an official journal of the American Association for Cancer Research.

Molecular and phenotypic profiling of colorectal cancer patients in West Africa reveals biological insights

N. Schultz, M. Berger, M. Gonen, 2021, Nature Communications.

Germline alterations in patients with biliary tract cancers: A spectrum of significant and previously underappreciated findings

M. Ladanyi, M. Berger, D. Solit, 2020, Cancer.

Prevalence of Germline Alterations on Targeted Tumor-Normal Sequencing of Esophagogastric Cancer

David R. Jones, S. Sihag, N. Schultz, 2021, JAMA network open.

A Comprehensive Comparison of Early-Onset and Average-Onset Colorectal Cancers.

B. Taylor, N. Schultz, K. Offit, 2021, Journal of the National Cancer Institute.

Early age of onset and broad cancer spectrum persist in MSH6- and PMS2-associated Lynch syndrome.

K. Offit, O. Ceyhan-Birsoy, Z. Stadler, 2022, Genetics in medicine : official journal of the American College of Medical Genetics.

Genetic Ancestry Correlates with Somatic Differences in a Real-World Clinical Cancer Sequencing Cohort.

N. Schultz, M. Ladanyi, M. Berger, 2022, Cancer discovery.

Germline drivers of gynecologic carcinosarcomas.

M. Berger, K. Offit, B. Weigelt, 2023, Gynecologic oncology.

Germline risk assessment and genetic counseling in ovarian cancer patients of diverse self-reported race/ethnicity and ancestry (388)

B. Weigelt, D. Chi, Z. Stadler, 2022, Gynecologic Oncology.

ATM Germline-Mutated Gastroesophageal Junction Adenocarcinomas: Clinical Descriptors, Molecular Characteristics, and Potential Therapeutic Implications

J. Reis-Filho, M. Koehler, O. Ceyhan-Birsoy, 2022, Journal of the National Cancer Institute.

Germline Pathogenic Variants Impact Clinicopathology of Advanced Lung Cancer.

B. Taylor, M. Ladanyi, M. Berger, 2022, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

Prevalence and Clinical Implications of Mismatch Repair-Proficient Colorectal Cancer in Patients With Lynch Syndrome.

M. Berger, K. Offit, M. Weiser, 2023, JCO precision oncology.

Comprehensive Analysis of Germline Drivers in Endometrial Cancer.

M. Berger, K. Offit, B. Weigelt, 2023, Journal of the National Cancer Institute.

Unique Genomic Alterations and Microbial Profiles Identified in Patients With Gastric Cancer of African, European, and Asian Ancestry

S. Sihag, N. Schultz, M. Berger, 2023, Annals of surgery.

Characterization of patients with multiple primary tumors.

V. Seshan, M. Berger, K. Offit, 2020 .

A tyrosyl-tRNA synthetase suppresses structural defects in the two major helical domains of the group I intron catalytic core.

G. Mohr, A. Lambowitz, C. A. Myers, 1996, Journal of molecular biology.

Pathogenic germline variants in non-BRCA1/2 homologous recombination genes in ovarian cancer: Analysis of tumor phenotype and survival.

N. Schultz, K. Offit, Ritika Kundra, 2023, Gynecologic oncology.

Pathogenic germline variants in patients with endometrial cancer of diverse ancestry.

K. Offit, B. Weigelt, A. Iasonos, 2023, Cancer.

Germline Pathogenic Variants and Genetic Counseling by Ancestry in Patients With Epithelial Ovarian Cancer.

Y. Liu, M. Berger, K. Offit, 2023, JCO precision oncology.

The impact of germline alterations in appendiceal adenocarcinoma.

N. Schultz, M. Berger, G. Nash, 2023, Clinical cancer research : an official journal of the American Association for Cancer Research.